204 related articles for article (PubMed ID: 38261141)
1. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
Garcia MA; Turner A; Brachman DG
J Neurooncol; 2024 Jan; 166(2):203-212. PubMed ID: 38261141
[TBL] [Abstract][Full Text] [Related]
2. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
[TBL] [Abstract][Full Text] [Related]
3. GammaTile
Gessler DJ; Ferreira C; Dusenbery K; Chen CC
Future Oncol; 2020 Oct; 16(30):2445-2455. PubMed ID: 32618209
[TBL] [Abstract][Full Text] [Related]
4. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
[TBL] [Abstract][Full Text] [Related]
5. Rapid Interval Recurrence of Glioblastoma Following Gross Total Resection: A Possible Indication for GammaTileⓇ Brachytherapy.
Easwaran TP; Sterling D; Ferreira C; Sloan L; Wilke C; Neil E; Shah R; Chen CC; Dusenbery KE
Cureus; 2021 Nov; 13(11):e19496. PubMed ID: 34912636
[TBL] [Abstract][Full Text] [Related]
6. First clinical implementation of GammaTile permanent brain implants after FDA clearance.
Ferreira C; Sterling D; Reynolds M; Dusenbery K; Chen C; Alaei P
Brachytherapy; 2021; 20(3):673-685. PubMed ID: 33487560
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of GammaTile intracranial brachytherapy implanted during awake craniotomy.
McClelland S; Gardner UG; Le Y; Ng SK; Shah MV; Watson GA
Brachytherapy; 2021; 20(6):1265-1268. PubMed ID: 34588144
[TBL] [Abstract][Full Text] [Related]
8. GammaTile
Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
[TBL] [Abstract][Full Text] [Related]
9. Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method.
Arsenault T; Labak CM; Chaung K; Muzic RF; Kardan A; Sloan A; Choi S; Podder T; Ouyang Z
Cureus; 2021 Nov; 13(11):e19232. PubMed ID: 34877209
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.
Koch MJ; Agarwalla PK; Royce TJ; Shih HA; Oh K; Niemierko A; Mauceri TC; Curry WT; Barker FG; Loeffler JS
Neurosurgery; 2019 Nov; 85(5):E910-E916. PubMed ID: 31329941
[TBL] [Abstract][Full Text] [Related]
11. Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review.
Odia Y; Gutierrez AN; Kotecha R
Neuro Oncol; 2022 Nov; 24(Suppl 6):S16-S24. PubMed ID: 36322100
[TBL] [Abstract][Full Text] [Related]
12. Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center.
Warren KT; Boucher A; Bray DP; Dresser S; Zhong J; Shu HK; Olson J; Hoang K
Cureus; 2021 Nov; 13(11):e19777. PubMed ID: 34950555
[TBL] [Abstract][Full Text] [Related]
13. GammaTile: Comprehensive Review of a Novel Radioactive Intraoperative Seed-Loading Device for the Treatment of Brain Tumors.
Ekhator C; Nwankwo I; Rak E; Homayoonfar A; Fonkem E; Rak R
Cureus; 2022 Oct; 14(10):e29970. PubMed ID: 36225241
[TBL] [Abstract][Full Text] [Related]
14. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
[TBL] [Abstract][Full Text] [Related]
15. The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials.
Palmisciano P; Haider AS; Balasubramanian K; D'Amico RS; Wernicke AG
J Neurooncol; 2022 Aug; 159(1):117-133. PubMed ID: 35696019
[TBL] [Abstract][Full Text] [Related]
16. Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
Imber BS; Young RJ; Beal K; Reiner AS; Giantini-Larsen AM; Krebs S; Yang JT; Aramburu-Nunez D; Cohen GN; Brennan C; Tabar V; Moss NS
J Neurooncol; 2022 Sep; 159(3):609-618. PubMed ID: 35896906
[TBL] [Abstract][Full Text] [Related]
17. Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.
Abou Al-Shaar H; Almefty KK; Abolfotoh M; Arvold ND; Devlin PM; Reardon DA; Loeffler JS; Al-Mefty O
J Neurooncol; 2015 Sep; 124(3):515-22. PubMed ID: 26253325
[TBL] [Abstract][Full Text] [Related]
18. GammaTile for Gliomas: A Single-Center Case Series.
Budnick HC; Richardson AM; Shiue K; Watson G; Ng SK; Le Y; Shah MV
Cureus; 2021 Nov; 13(11):e19390. PubMed ID: 34925992
[TBL] [Abstract][Full Text] [Related]
19. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
Bander ED; Kelly A; Ma X; Christos PJ; Wernicke AG; Stieg PE; Trichter S; Knisely JPS; Ramakrishna R; Schwartz TH
J Neurooncol; 2023 Jun; 163(2):355-365. PubMed ID: 37249824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
